![Moses Goddard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Moses Goddard
Corporate Officer/Principal bei Semma Therapeutics, Inc.
Profil
Moses Goddard is the founder of CytoSolv, Inc., a company founded in 2009.
He held the title of President, Secretary, Treasurer & Director at CytoSolv, Inc. Dr. Goddard is currently working as the Vice President-Surgery at Semma Therapeutics, Inc.
Aktive Positionen von Moses Goddard
Unternehmen | Position | Beginn |
---|---|---|
Semma Therapeutics, Inc.
![]() Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 18.12.2018 |
Ehemalige bekannte Positionen von Moses Goddard
Unternehmen | Position | Ende |
---|---|---|
CytoSolv, Inc.
![]() CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology CytoSolv, Inc. develops proprietary technology to address wound healing. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function. The company was founded by Moses Goddard and Christopher D. Thanos in 2009 and is headquartered in Providence, RI. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
CytoSolv, Inc.
![]() CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology CytoSolv, Inc. develops proprietary technology to address wound healing. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function. The company was founded by Moses Goddard and Christopher D. Thanos in 2009 and is headquartered in Providence, RI. | Health Technology |
Semma Therapeutics, Inc.
![]() Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Health Technology |